Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.08 - $809.55 $40 - $404,775
-500 Reduced 1.33%
37,200 $0
Q3 2022

Nov 14, 2022

BUY
$0.17 - $765.0 $6,409 - $28.8 Million
37,700 New
37,700 $3,000
Q2 2022

Aug 12, 2022

SELL
$0.27 - $0.71 $3,969 - $10,437
-14,700 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$0.38 - $1.07 $1,189 - $3,349
3,130 Added 27.05%
14,700 $2,000
Q4 2021

Feb 14, 2022

BUY
$1.03 - $2.48 $11,917 - $28,693
11,570 New
11,570 $1,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $120M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.